Becoming the Partner of Choice, One Step at a Time

Leading companies in the pharmaceutical and biotechnology industry today are demanding, as they should be. Contract development and manufacturing organizations like Vetter are entrused with the jewels of their client i.e., biotechnology and pharmaceutical products worth billions of euros. Of course, producing prefilled drug delivery systems for clients that measure up to exacting and demanding standards of global regulatory authorities requires investment in modern production sites and technology. But success also requires vision and a sound strategy. In an interview with Biotechnology and Life Sciences medium biopro.de, Peter Soelkner, Managing Director of Vetter Pharma International discusses how Vetter has taken a step-by-step approach to achieve a leadership status in this industry over the last 20+ years, and reveals some of the company’s strategies for moving forward in this ever-changing, challenging market.